319 related articles for article (PubMed ID: 25666906)
1. Glucocorticoids and the non-steroidal selective glucocorticoid receptor modulator, compound A, differentially affect colon cancer-derived myofibroblasts.
Drebert Z; Bracke M; Beck IM
J Steroid Biochem Mol Biol; 2015 May; 149():92-105. PubMed ID: 25666906
[TBL] [Abstract][Full Text] [Related]
2. Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor Transrepression.
Zheng Y; Ishiguro H; Ide H; Inoue S; Kashiwagi E; Kawahara T; Jalalizadeh M; Reis LO; Miyamoto H
Mol Endocrinol; 2015 Oct; 29(10):1486-97. PubMed ID: 26322830
[TBL] [Abstract][Full Text] [Related]
3. The autophagy receptor SQSTM1/p62 mediates anti-inflammatory actions of the selective NR3C1/glucocorticoid receptor modulator compound A (CpdA) in macrophages.
Mylka V; Deckers J; Ratman D; De Cauwer L; Thommis J; De Rycke R; Impens F; Libert C; Tavernier J; Vanden Berghe W; Gevaert K; De Bosscher K
Autophagy; 2018; 14(12):2049-2064. PubMed ID: 30215534
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effect of non-steroid glucocorticoid receptor ligand CpdA on leukemia cell lines CEM and K562.
Lesovaya EA; Yemelyanov AY; Kirsanov KI; Yakubovskaya MG; Budunova IV
Biochemistry (Mosc); 2011 Nov; 76(11):1242-52. PubMed ID: 22117551
[TBL] [Abstract][Full Text] [Related]
5. Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer.
Chen Z; Lan X; Wu D; Sunkel B; Ye Z; Huang J; Liu Z; Clinton SK; Jin VX; Wang Q
Nat Commun; 2015 Sep; 6():8323. PubMed ID: 26374485
[TBL] [Abstract][Full Text] [Related]
6. Differential cytokine profiles upon comparing selective versus classic glucocorticoid receptor modulation in human peripheral blood mononuclear cells and inferior turbinate tissue.
Beck IM; Van Crombruggen K; Holtappels G; Daubeuf F; Frossard N; Bachert C; De Bosscher K
PLoS One; 2015; 10(4):e0123068. PubMed ID: 25875480
[TBL] [Abstract][Full Text] [Related]
7. A plant-derived glucocorticoid receptor modulator attenuates inflammation without provoking ligand-induced resistance.
Gossye V; Elewaut D; Van Beneden K; Dewint P; Haegeman G; De Bosscher K
Ann Rheum Dis; 2010 Jan; 69(1):291-6. PubMed ID: 19204014
[TBL] [Abstract][Full Text] [Related]
8. Classic glucocorticoids versus non-steroidal glucocorticoid receptor modulators: survival of the fittest regulator of the immune system?
De Bosscher K; Beck IM; Haegeman G
Brain Behav Immun; 2010 Oct; 24(7):1035-42. PubMed ID: 20600811
[TBL] [Abstract][Full Text] [Related]
9. Colon cancer-derived myofibroblasts increase endothelial cell migration by glucocorticoid-sensitive secretion of a pro-migratory factor.
Drebert Z; MacAskill M; Doughty-Shenton D; De Bosscher K; Bracke M; Hadoke PWF; Beck IM
Vascul Pharmacol; 2017 Feb; 89():19-30. PubMed ID: 27717848
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the dissociated steroid RU24858 does not exclude a role for inducible genes in the anti-inflammatory actions of glucocorticoids.
Chivers JE; Gong W; King EM; Seybold J; Mak JC; Donnelly LE; Holden NS; Newton R
Mol Pharmacol; 2006 Dec; 70(6):2084-95. PubMed ID: 16988013
[TBL] [Abstract][Full Text] [Related]
11. The possible separation of 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation and hyperplasia by compound A.
Kowalczyk P; Kowalczyk MC; Junco JJ; Tolstykh O; Kinjo T; Truong H; Walaszek Z; Hanausek M; Slaga TJ
Mol Carcinog; 2013 Jun; 52(6):488-96. PubMed ID: 22351517
[TBL] [Abstract][Full Text] [Related]
12. The rigid steroid 21-hydroxy-6,19-epoxyprogesterone (21OH-6,19OP) is a dissociated glucocorticoid receptor modulator potentially useful as a novel coadjuvant in breast cancer chemotherapy.
Orqueda AJ; Dansey MV; Español A; Veleiro AS; Bal de Kier Joffé E; Sales ME; Burton G; Pecci A
Biochem Pharmacol; 2014 Jun; 89(4):526-35. PubMed ID: 24735610
[TBL] [Abstract][Full Text] [Related]
13. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K
Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834
[TBL] [Abstract][Full Text] [Related]
14. Selective prostacyclin receptor agonism augments glucocorticoid-induced gene expression in human bronchial epithelial cells.
Wilson SM; Shen P; Rider CF; Traves SL; Proud D; Newton R; Giembycz MA
J Immunol; 2009 Nov; 183(10):6788-99. PubMed ID: 19880449
[TBL] [Abstract][Full Text] [Related]
15. Selective modulation through the glucocorticoid receptor ameliorates muscle pathology in mdx mice.
Huynh T; Uaesoontrachoon K; Quinn JL; Tatem KS; Heier CR; Van Der Meulen JH; Yu Q; Harris M; Nolan CJ; Haegeman G; Grounds MD; Nagaraju K
J Pathol; 2013 Oct; 231(2):223-35. PubMed ID: 23794417
[TBL] [Abstract][Full Text] [Related]
16. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I
Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523
[TBL] [Abstract][Full Text] [Related]
17. A dissociated glucocorticoid receptor modulator reduces airway hyperresponsiveness and inflammation in a mouse model of asthma.
Reber LL; Daubeuf F; Plantinga M; De Cauwer L; Gerlo S; Waelput W; Van Calenbergh S; Tavernier J; Haegeman G; Lambrecht BN; Frossard N; De Bosscher K
J Immunol; 2012 Apr; 188(7):3478-87. PubMed ID: 22393156
[TBL] [Abstract][Full Text] [Related]
18. Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds.
Sundahl N; Bridelance J; Libert C; De Bosscher K; Beck IM
Pharmacol Ther; 2015 Aug; 152():28-41. PubMed ID: 25958032
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids indirectly decrease colon cancer cell proliferation and invasion via effects on cancer-associated fibroblasts.
Drebert Z; De Vlieghere E; Bridelance J; De Wever O; De Bosscher K; Bracke M; Beck IM
Exp Cell Res; 2018 Jan; 362(2):332-342. PubMed ID: 29196164
[TBL] [Abstract][Full Text] [Related]
20. Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?
Newton R; Holden NS
Mol Pharmacol; 2007 Oct; 72(4):799-809. PubMed ID: 17622575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
